LLY vs SLB: Which Is the Better Buy?
Side-by-side comparison of Eli Lilly and Company and Slb N.V. — fair value, conviction, valuation metrics, and QuantHub research signals.
Updated 2026-09-26.
Eli Lilly and Company · Healthcare
$1,183.72
+2.1% upside to fair value
Med Conviction
Grade B
High Quality
VS
Slb N.V. · Energy
$52.08
+8.6% upside to fair value
Med Conviction
Grade B
QuantHub Verdict
SLB has more upside to fair value
(+8.6%).
These are model outputs — not personalized investment advice.
See all research →
Valuation & Fundamentals
| Metric |
LLY |
SLB |
| Current Price |
$1,183.72 |
$52.08 |
| Fair Value Estimate |
$1,208.00 |
$56.56 |
| Upside to Fair Value |
+2.1%
|
+8.6%
|
| Market Cap |
$1,114.8B |
$77.3B |
| Forward P/E |
—
|
—
|
| EV / EBITDA |
26.8x
|
12.2x
|
| Price / Sales |
14.0x
|
2.1x
|
| Price / FCF |
52.7x
|
17.1x
|
| Revenue Growth YoY |
+47.7%
|
+5.0%
|
| Gross Margin |
83.4%
|
16.5%
|
| Operating Margin |
49.7%
|
13.4%
|
| Return on Equity |
92.6%
|
11.8%
|
| Dividend Yield |
0.57% |
2.25% |
| FCF Yield |
1.9%
|
5.83%
|
| Analyst Consensus |
Strong Buy
|
Strong Buy
|
Investment Thesis
Eli Lilly is a global pharmaceutical company whose incretin franchise, led by Mounjaro and Zepbound, has become the dominant growth engine in diabetes and obesity care. The business quality is high: TTM gross margin is 83.4%, TTM operating margin is 49.7%, TTM net margin is 33.5%, and ROE is 92.6%, while revenue grew 47.7% and earnings grew 25.3% in the most recent quarter on a year-over-year bas…
SLB N.V. is the world's largest oilfield services provider, operating four divisions (Digital & Integration, Reservoir Performance, Well Construction, and Production Systems) that span field development, drilling, subsea production, and carbon management for the global energy industry. The business carries a medium-quality profile: it benefits from deep technical expertise, a broad international …
Accumulation Zones
| Metric |
LLY |
SLB |
| Zone Low |
$906.00 |
$42.42 |
| Zone High |
$1,026.80 |
$48.08 |
| In Buy Zone? |
No
|
No
|